Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Eligibility is based on body mass index (BMI) plus specific qualifying conditions, organized into three tiers covered in detail in our Medicare GLP-1 Bridge eligibility post
Muscle Loss = Less Energy Output Weight loss on GLP-1s includes some muscle loss unless you actively work to prevent it
and is expected to launch in early January 2026
The GLP-1 drug is similar to Ozempic, which is used to treat weight-loss related issues
Inflammatory bowel conditions, leaky gut syndrome, and other gastrointestinal issues may respond to BPC-157's protective and healing effects
The upper panel of Figure 2 illustrates the direction of these effects: blue regions showed predominantly decreased BOLD responses, red regions showed increased responses, and yellow regions exhibited mixed findings across studies
